DOW vs EBS
Dow Inc (DOW) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
Dow Inc (DOW) is a chemicals company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported DOW revenue for 2024-12-31 was $42.96B. Net income was $1.20B. Revenue was down 3.7% from 2023-12-31 to 2024-12-31. DOW currently screens at market cap $20.89B and trailing P/E 73.9.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
DOW currently screens at market cap $20.89B and trailing P/E 73.9. EBS currently screens at market cap $416.4M.
Not investment advice. Open the DOW and EBS stock pages for the full models.
Not investment advice.